創薬薬物動態研究におけるハイスループットLC/MS
スポンサーリンク
概要
- 論文の詳細を見る
Pharmacokenetic (PK) properties have been recognized as one of the most important attrition factors in the drug development. Recently, there has been a substantial increase in the variety and number of newly synthesized compounds in the drug discovery stage. Therefore, an improved capacity to evaluate such huge numbers of compounds is one of the most important needs for high-throughput screening. One key to successful analysis technology for PK studies is the LC/MS. However, there is a problem to establishing high-throughput LC/MS. It is important that a suitable LC system is selected from various instruments to analyze with accuracy. For example, short columns, parallel LC systems, unique types of columns, and high flow assays have been examined to find the most rapid and efficient analysis systems. Impurities from reaction mixture or medium should be separated from analytes to get stable detection, as those can alter the ion effect of analytes. In addition to developing these methods, keeping the LC/MS system a good working order is also important, as high-throughput LC/MS is used for continuous screening. High-throughput LC/MS will be indispensable technology to PK studies in drug discovery, but much work has to be done in order to determine which optimal condition will be developed.
- 日本質量分析学会の論文
- 2004-06-01
著者
-
岩崎 一秀
ファイザー製薬・薬物動態研
-
長根尾 富治
ファイザー製薬中央研究所薬物代謝研究室
-
長根尾 富治
ファイザー(株)中央研究所 薬物動態研究部
-
岩崎 一秀
ファイザー製薬・中央研
-
岩崎 一秀
ファイザー(株)中央研究所
関連論文
- 1-aminobenzotriazoleのヒト肝チトクロームP-450阻害におけるアイソフォーム選択性
- Caco-2 permeability の in silico の予測
- ヒト肝ミクロソーム代謝における CYP2D6 の関与を評価する新しい方法
- 創薬薬物動態研究におけるハイスループットLC/MS
- CYP3A4に遺伝子多型が存在するか?
- 平成18年度日本薬物動態学会北川賞を受賞して
- 13th NA ISSX Meeting/20th JSSX Meeting に参加して
- 平成16年度日本薬物動態学会年会ベストポスター賞選考に参加して